| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3876692 | The Journal of Urology | 2006 | 5 Pages |
Abstract
This study demonstrates that the predictive ability of PSA as a cancer outcomes biomarker has not changed significantly since the beginning of the PSA era. Despite suggestions to the contrary, PSA remains an important variable in predicting risk of BCF after RP.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Robert E. Mitchell, Manisha Desai, Jay B. Shah, Carl A. Olsson, Mitchell C. Benson, James M. McKiernan,